购买价格
25.33
25.33
25.32
233.06 B
有关过去业绩的信息并不是未来业绩的可靠指标。
The company's stock has under-performed its sector so far in 2024, while the company managed to beat EPS consensus estimates during the last quarter results. Meanwhile, Pfizer has been increasing its dividend consistently year-over-year for the last 7 years, becoming an attractive stock for dividend income-oriented investors. Additionally, Pfizer has a strong product pipeline that could potentially produce additional revenue streams in the future. Going forward, competition from generic drugs and pricing pressures remain the company's most important headwinds.
创建账户并完成快速验证。
通过银行卡、银行转账或加密货币向钱包充值。
选择 PFE,设置金额,然后点击买入或卖出,仅此而已!
Pfizer Inc.
PFE
25.325
+0.68%
常见问题